TCR recognition of peptide/MHC class II complexes and superantigens

Seminars in Immunology

Volumn 19, Issue 4, 2007, Pages 262-271

  Sundberg, Eric J ^a   Deng, Lu ^b   Mariuzza, Roy A ^b  

^a BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

Author keywords

Major histocompatibility complex; Peptide antigen; Superantigen; T cell activity; T cell receptor

Indexed keywords

BACTERIAL TOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE DERIVATIVE; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; AUTOIMMUNITY; CELLULAR IMMUNITY; HUMAN; IMMUNOSURVEILLANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; REVIEW; T LYMPHOCYTE; TOXIC SHOCK SYNDROME;

ANTIGEN PRESENTATION; AUTOANTIGENS; AUTOIMMUNITY; BACTERIA; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR1 ANTIGEN; HUMANS; MODELS, MOLECULAR; NEOPLASMS; PEPTIDES; PROTEIN CONFORMATION; RECEPTORS, ANTIGEN, T-CELL; SUPERANTIGENS;

EID: 34447278825     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2007.04.006     Document Type: Review

References (68)

1. Rosenberg S.A. Progress in human tumour immunology and immunotherapy. Nature 411 6835 (2001) 380-384
2. Houghton A.N., and Guevara-Patino J.A. Immune recognition of self in immunity against cancer. J Clin Invest 114 4 (2004) 468-471
3. Engelhorn M.E., Guevara-Patino J.A., Noffz G., Hooper A.T., Lou O., Gold J.S., et al. Autoimmunity and tumor immunity induced by immune responses to mutations in self. Nat Med 12 2 (2006) 198-206
4. Rudolph M.G., Stanfield R.L., and Wilson I.A. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24 (2006) 419-466
5. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 23 (2005) 683-747
6. Kent S.C., Chen Y., Bregoli L., Clemmings S.M., Kenyon N.S., Ricordi C., et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 435 7039 (2005) 224-228
7. Nepom G.T., Lippolis J.D., White F.M., Masewicz S., Marto J.A., Herman A., et al. Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc Natl Acad Sci USA 98 4 (2001) 1763-1768
8. Ohashi P.S. Negative selection and autoimmunity. Curr Opin Immunol 15 6 (2003) 668-676
9. Derbinski J., Schulte A., Kyewski B., and Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2 11 (2001) 1032-1039
10. Klein L., Klugmann M., Nave K.A., Tuohy V.K., and Kyewski B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat Med 6 1 (2000) 56-61
11. Kappler J.W., Roehm N., and Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 49 2 (1987) 273-280
12. Alam S.M., Travers P.J., Wung J.L., Nasholds W., Redpath S., Jameson S.C., et al. T-cell-receptor affinity and thymocyte positive selection. Nature 381 6583 (1996) 616-620
13. Anderton S.M., Radu C.G., Lowrey P.A., Ward E.S., and Wraith D.C. Negative selection during the peripheral immune response to antigen. J Exp Med 193 1 (2001) 1-11
14. Pieper R., Christian R.E., Gonzales M.I., Nishimura M.I., Gupta G., Settlage R.E., et al. Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells. J Exp Med 189 5 (1999) 757-766
15. Nicholson M.J., Hahn M., and Wucherpfennig K.W. Unusual features of self-peptide/MHC binding by autoimmune T cell receptors. Immunity 23 4 (2005) 351-360
16. Maynard J., Petersson K., Wilson D.H., Adams E.J., Blondelle S.E., Boulanger M.J., et al. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity 22 1 (2005) 81-92
17. Li Y., Huang Y., Lue J., Quandt J.A., Martin R., and Mariuzza R.A. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J 24 17 (2005) 2968-2979
18. Hahn M., Nicholson M.J., Pyrdol J., and Wucherpfennig K.W. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat Immunol 6 5 (2005) 490-496
19. Deng L., Langley R.J., Brown P.H., Xu G., Teng L., Wang Q., et al. Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor. Nat Immunol (2007)
20. Clements C.S., Dunstone M.A., Macdonald W.A., McCluskey J., and Rossjohn J. Specificity on a knife-edge: the alphabeta T cell receptor. Curr Opin Struct Biol 16 6 (2006) 787-795
21. Hennecke J., Carfi A., and Wiley D.C. Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J 19 21 (2000) 5611-5624
22. Reinherz E.L., Tan K., Tang L., Kern P., Liu J., Xiong Y., et al. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 286 5446 (1999) 1913-1921
23. Hausmann S., Martin M., Gauthier L., and Wucherpfennig K.W. Structural features of autoreactive TCR that determine the degree of degeneracy in peptide recognition. J Immunol 162 1 (1999) 338-344
24. Hemmer B., Pinilla C., Gran B., Vergelli M., Ling N., Conlon P., et al. Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency. J Immunol 164 2 (2000) 861-871
25. He X.L., Radu C., Sidney J., Sette A., Ward E.S., and Garcia K.C. Structural snapshot of aberrant antigen presentation linked to autoimmunity: the immunodominant epitope of MBP complexed with I-Au. Immunity 17 1 (2002) 83-94
26. van der Merwe P.A., and Davis S.J. Molecular interactions mediating T cell antigen recognition. Annu Rev Immunol 21 (2003) 659-684
27. Kedl R.M., Kappler J.W., and Marrack P. Epitope dominance, competition and T cell affinity maturation. Curr Opin Immunol 15 1 (2003) 120-127
28. Goodnow C.C., Sprent J., Fazekas de St Groth B., and Vinuesa C.G. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435 7042 (2005) 590-597
29. Gronski M.A., Boulter J.M., Moskophidis D., Nguyen L.T., Holmberg K., Elford A.R., et al. TCR affinity and negative regulation limit autoimmunity. Nat Med 10 11 (2004) 1234-1239
30. Zehn D., and Bevan M.J. T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity 25 2 (2006) 261-270
31. McCormick J.K., Yarwood J.M., and Schlievert P.M. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 55 (2001) 77-104
32. Sundberg E.J., Li Y., and Mariuzza R.A. So many ways of getting in the way: diversity in the molecular architecture of superantigen-dependent T-cell signaling complexes. Curr Opin Immunol 14 1 (2002) 36-44
33. Proft T., and Fraser J.D. Bacterial superantigens. Clin Exp Immunol 133 3 (2003) 299-306
34. Brouillard J.N., Gunther S., Varma A.K., Gryski I., Herfst C.A., Rahman A.K., et al. Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by Group V superantigens. J Mol Biol 367 (2007) 925-934
35. Kim J., Urban R.G., Strominger J.L., and Wiley D.C. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 266 5192 (1994) 1870-1874
36. Wen R., Cole G.A., Surman S., Blackman M.A., and Woodland D.L. Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells. J Exp Med 183 3 (1996) 1083-1092
37. Moza B., Varma A.K., Zhu P., Buonpane R.A., Herfst C.A., Nicholson M.J., et al. Structural basis of T cell receptor specificity and activation by the bacterial superantigen TSST-1. EMBO J 26 4 (2007) 1187-1197
38. Moza B., Buonpane R.A., Zhu P., Herfst C.A., Rahman A.K., McCormick J.K., et al. Long-range cooperative binding effects in a T cell receptor variable domain. Proc Natl Acad Sci USA 103 26 (2006) 9867-9872
39. Jardetzky T.S., Brown J.H., Gorga J.C., Stern L.J., Urban R.G., Chi Y.I., et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368 6473 (1994) 711-718
40. Fields B.A., Malchiodi E.L., Li H., Ysern X., Stauffacher C.V., Schlievert P.M., et al. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature 384 6605 (1996) 188-192
41. Li H., Llera A., Tsuchiya D., Leder L., Ysern X., Schlievert P.M., et al. Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity 9 6 (1998) 807-816
42. Sundberg E.J., Li H., Llera A.S., McCormick J.K., Tormo J., Schlievert P.M., et al. Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. Structure 10 5 (2002) 687-699
43. Abrahmsen L., Dohlsten M., Segren S., Bjork P., Jonsson E., and Kalland T. Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J 14 13 (1995) 2978-2986
44. Hudson K.R., Tiedemann R.E., Urban R.G., Lowe S.C., Strominger J.L., and Fraser J.D. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II. J Exp Med 182 3 (1995) 711-720
45. Petersson K., Thunnissen M., Forsberg G., and Walse B. Crystal structure of a SEA variant in complex with MHC class II reveals the ability of SEA to crosslink MHC molecules. Structure 10 12 (2002) 1619-1626
46. Petersson K., Hakansson M., Nilsson H., Forsberg G., Svensson L.A., Liljas A., et al. Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence. EMBO J 20 13 (2001) 3306-3312
47. Li Y., Li H., Dimasi N., McCormick J.K., Martin R., Schuck P., et al. Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity 14 1 (2001) 93-104
48. Sundberg E.J., Li H., Llera A.S., McCormick J.K., Tormo J., Schlievert P.M., et al. Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. Structure (Camb) 10 5 (2002) 687-699
49. Rahman A.K., Herfst C.A., Moza B., Shames S.R., Chau L.A., Bueno C., et al. Molecular basis of TCR selectivity, cross-reactivity, and allelic discrimination by a bacterial superantigen: integrative functional and energetic mapping of the SpeC-Vbeta2.1 molecular interface. J Immunol 177 12 (2006) 8595-8603
50. Fernandez M.M., Guan R., Swaminathan C.P., Malchiodi E.L., and Mariuzza R.A. Crystal structure of staphylococcal enterotoxin I (SEI) in complex with a human major histocompatibility complex class II molecule. J Biol Chem 281 35 (2006) 25356-25364
51. Gunther S., Varma A.K., Moza B., Kasper K.J., Wyatt A.W., Zhu P., et al. A novel loop domain in superantigens extends their T cell receptor recognition site. J Mol Biol 371 1 (2007) 210-221
52. Petersson K., Pettersson H., Skartved N.J., Walse B., and Forsberg G. Staphylococcal enterotoxin H induces V alpha-specific expansion of T cells. J Immunol 170 8 (2003) 4148-4154
53. Wang L., Zhao Y., Li Z., Guo Y., Jones L.L., Kranz D.M., et al. Crystal structure of a complete ternary complex of TCR, superantigen and peptide-MHC. Nat Struct Mol Biol (2007)
54. Buonpane R.A., Moza B., Sundberg E.J., and Kranz D.M. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1. J Mol Biol 353 2 (2005) 308-321
55. Andersen P.S., Lavoie P.M., Sekaly R.P., Churchill H., Kranz D.M., Schlievert P.M., et al. Role of the T cell receptor alpha chain in stabilizing TCR-superantigen-MHC class II complexes. Immunity 10 4 (1999) 473-483
56. Davis M.M., Boniface J.J., Reich Z., Lyons D., Hampl J., Arden B., et al. Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol 16 (1998) 523-544
57. Malchiodi E.L., Eisenstein E., Fields B.A., Ohlendorf D.H., Schlievert P.M., Karjalainen K., et al. Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J Exp Med 182 6 (1995) 1833-1845
58. Andersen P.S., Schuck P., Sundberg E.J., Geisler C., Karjalainen K., and Mariuzza R.A. Quantifying the energetics of cooperativity in a ternary protein complex. Biochemistry 41 16 (2002) 5177-5184
59. Rahman A.K.M.N., Herfst C.A., Moza B., Chau L.A., Bueno C., Madrenas J., et al. Molecular basis of T cell receptor selectivity, cross-reactivity and allelic discrimination by a bacterial superantigen: integrative functional and energetic mapping of the SpeC-Vb2.1 molecular interface. J Immunol 17 12 (2006)
60. Kaul R., McGeer A., Norrby-Teglund A., Kotb M., Schwartz B., O'Rourke K., et al., The Canadian Streptococcal Study Group. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. Clin Infect Dis 28 4 (1999) 800-807
61. LeClaire R.D., and Bavari S. Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality. Antimicrob Agents Chemother 45 2 (2001) 460-463
62. Hamad A.R., Herman A., Marrack P., and Kappler J.W. Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B. J Exp Med 180 2 (1994) 615-621
63. Pang L.T., Kum W.W., and Chow A.W. Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody. Infect Immun 68 6 (2000) 3261-3268
64. Jo D., Liu D., Yao S., Collins R.D., and Hawiger J. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med 11 8 (2005) 892-898
65. Buonpane R.A., Churchill H.R.O., Moza B., Sundberg E.J., Peterson M.L., Schlievert P.M., et al. Neutralization of staphylococcal enterotoxin B by soluble, high affinity receptor antagonists. Nat Med 13 (2007) 725-729
66. Kieke M.C., Sundberg E., Shusta E.V., Mariuzza R.A., Wittrup K.D., and Kranz D.M. High affinity T cell receptors from yeast display libraries block T cell activation by superantigens. J Mol Biol 307 5 (2001) 1305-1315
67. Kane L.P., Lin J., and Weiss A. Signal transduction by the TCR for antigen. Curr Opin Immunol 12 3 (2000) 242-249
68. Bueno C., Lemke C.D., Criado G., Baroja M.L., Ferguson S.S., Rahman A.K., et al. Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Galpha11-dependent, PLC-beta-mediated pathway. Immunity 25 1 (2006) 67-78